A simpler form of DNA may be key to non-viral gene therapy, study suggestsnews2026-03-12T15:31:55+00:00March 12th, 2026|Endpoints News|
Study suggests long non-coding RNA has potential as new class of genetic medicinenews2026-03-10T20:02:18+00:00March 10th, 2026|Endpoints News|
RNA editing startup Tacit Therapeutics launches with $19M for brain diseasesnews2026-03-09T13:00:55+00:00March 9th, 2026|Endpoints News|
Tenaya wins support from Alnylam in cardio disease pactnews2026-03-05T16:06:00+00:00March 5th, 2026|Endpoints News|
China is taking on the world’s 10 most expensive medicinesnews2026-03-05T15:00:17+00:00March 5th, 2026|Endpoints News|
Prime Medicine reverses course to seek FDA approval of shelved therapynews2026-03-03T20:48:13+00:00March 3rd, 2026|Endpoints News|
UniQure says FDA prefers randomized trial for Huntington’s treatmentnews2026-03-02T12:35:27+00:00March 2nd, 2026|Endpoints News|
Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapynews2026-02-25T12:00:38+00:00February 25th, 2026|Endpoints News|
BioMarin fails to find buyer, pulls Roctavian gene therapy off marketnews2026-02-24T16:17:44+00:00February 24th, 2026|Endpoints News|
FDA unveils long-awaited guidance on new pathway for individualized therapiesnews2026-02-23T16:30:45+00:00February 23rd, 2026|Endpoints News|
